Top Markets
#1 Black Phoenix Black Phoenix +354.75%
#2 Akedo Akedo +92.63%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +59.96%
#5 Acurast Acurast +37.34%
#6 OpenEden OpenEden +35.98%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.45%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +20.43%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Pozycja w akcjach #40631
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Cena akcji
$0.00045794
Ostatnia synchronizacja: 2025-07-11
Kapitalizacja rynkowa
$107.51K
Zmiana (1 dzień)
-36.01%
Zmiana (1 rok)
0.00%
Kraj
DK
Handel Scandion Oncology A/S (SCOL)

Kategoria

Healthcare
Historia stopy dywidendy dla Scandion Oncology A/S (SCOL)
Stopa dywidendy (TTM) dla Scandion Oncology A/S (symbol akcji: SCOL) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Scandion Oncology A/S (SCOL) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE